A Multicenter Randomized Double-Blind Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)

Go Back to All Clinical Trials

A Multicenter Randomized Double-Blind Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)

Brief description of study

The purpose of collecting your pregnancy information is to see if RE104 has any effects on pregnancy, its outcome, and the birth and health of a baby.

Clinical Study Identifier: s24-00310

ClinicalTrials.gov Identifier: NCT06342310

Principal Investigator: Stephen Ross.

Other Investigators: Joshua Siegel, Daniel Edward Roberts, Xiaojue Hu, Richard J Zeifman, Kelley O'Donnell.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies